Exploring hypoxia-related genes as prognostic indicators in lung adenocarcinoma
PLOS One · 03.06.2026 · 21 (6) · e0349820
DOI: 10.1371/journal.pone.0349820 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 03.06.2026. Verfasst von Bandar Alghamdi und 1 weiteren Autor:innen. Beteiligte Einrichtung: King Fahad Army Forces Hospital, Cardiology and Cardiac Surgery Center, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, Biomarkers, Tumor, Hypoxia. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
Background
Lung adenocarcinoma (LUAD) is a leading cause of cancer-related mortality, with hypoxia contributing to tumor progression and treatment resistance. Identifying hypoxia-related biomarkers could enhance prognosis and therapeutic strategies for LUAD.
Methods
This study aimed to identify hypoxia-related differentially expressed genes (HRDEGs) in lung adenocarcinoma (LUAD) through differential expression analysis. Functional analysis and protein-protein interaction (PPI) network construction were performed to explore the biological roles and interactions of these genes. Kaplan-Meier survival analysis, univariate Cox regression, and Lasso regression were used to identify key genes associated with survival. Multivariate Cox regression was then conducted to assess independent prognostic factors.
Results
This analysis revealed 283 upregulated HRDEGs and 322 downregulated HRDEGs in LUAD. Functional enrichment analysis indicated that the upregulated genes were primarily involved in cancer-related and cellular signaling pathways, while downregulated genes were associated with immunity-related pathways. We further identified 201 common upregulated hub genes (including MMP9, CDH1, HSP90AB1, SOX2, CDKN2A, SPP1, EZH2 ) and 224 common downregulated hub genes (such as IL6, TNF, IL1B, JUN, CCL2, TLR4, FOS, PTGS2 ). Kaplan-Meier survival analysis, univariate Cox regression, and Lasso regression led to the identification of 17 key genes ( ADRB2, ALDH2, CAT, CCNE1, MAP3K8, DSG2, EIF6, ABCB1, PIK3R1, RAD51, SFTPD, SOD3, CLEC3B, ADAM12, EXO1, FBLN5, and IGF2BP3 ) associated with patient survival. Finally, multivariate Cox regression analysis identified DSG2, EIF6, and EXO1 as independent prognostic factors for LUAD, highlighting their potential as biomarkers for prognosis and therapeutic targets in lung cancer.
Conclusion
In conclusion, DSG2, EIF6, and EXO1 were identified as key hypoxia-related genes in lung adenocarcinoma. These genes were found to be independent prognostic factors, highlighting their potential as biomarkers for predicting patient survival and guiding future therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- King Fahad Army Forces Hospital, Cardiology and Cardiac Surgery Center, Jeddah, Saudi Arabia.
- Department of Biochemistry, Cell and Systems Biology, Institute of Systems Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
ORCID-Profile: Sonia Rocha
Förderung
- Wellcome Trust
Zitieren
APA
Alghamdi, B., & Rocha, S. (2026). Exploring hypoxia-related genes as prognostic indicators in lung adenocarcinoma. PLOS One, 21(6), e0349820. https://doi.org/10.1371/journal.pone.0349820
Vancouver
Alghamdi B, Rocha S. Exploring hypoxia-related genes as prognostic indicators in lung adenocarcinoma. PLOS One. 2026;21(6):e0349820. doi:10.1371/journal.pone.0349820
BibTeX
@article{Alghamdi2026,
author = {Alghamdi, Bandar and Rocha, Sonia},
title = {Exploring hypoxia-related genes as prognostic indicators in lung adenocarcinoma},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {6},
pages = {e0349820},
doi = {10.1371/journal.pone.0349820}
}
EUVIMED